Association of low levels of mannan-binding protein with a common defect of opsonisation

M Super1, S Thiel, J Lu

  • 1Department of Immunology, University of London.

Lancet (London, England)
|November 25, 1989
PubMed

Insights

A common defect in yeast opsonisation is linked to low mannan-binding protein (MBP) levels. Supplementing MBP corrected this defect, highlighting its crucial role in the immune response.

Area of Science:

  • Immunology
  • Microbiology

Background:

  • 5-7% of the population exhibits a defect in opsonising Saccharomyces cerevisiae (baker's yeast).
  • This defect is associated with reduced levels of mannan-binding protein (MBP), a calcium-dependent serum lectin.

Purpose of the Study:

  • To investigate the link between low mannan-binding protein (MBP) levels and the defect in yeast opsonisation.
  • To determine if purified MBP can correct the opsonic defect in vitro.

Main Methods:

  • An in-vitro assay was used to measure complement moiety deposition on a mannan-coated surface.
  • Serum MBP levels were measured and correlated with C3b opsonin generation in healthy blood donors.
  • MBP levels were compared between children with the opsonic defect and a paediatric control group.

Main Results:

  • Purified MBP corrected the yeast opsonisation defect in a dose-dependent manner.
  • A significant correlation was found between serum MBP levels and C3b opsonin generation.
  • Children with the opsonic defect had significantly lower median MBP levels (4.9 µg/l) compared to controls (143 µg/l).

Conclusions:

  • Low serum mannan-binding protein (MBP) levels are directly linked to the common defect in Saccharomyces cerevisiae opsonisation.
  • MBP plays a critical role in complement-mediated opsonisation and innate immunity.
  • MBP supplementation is a potential therapeutic strategy for individuals with this opsonic defect.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...